Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
63.2M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
34.5K
-
Shares change
-
-213K
-
Total reported value, excl. options
-
$440K
-
Value change
-
-$2.78M
-
Number of sells
-
-2
-
Price
-
$12.75
Significant Holders of TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) as of Q4 2023
3 filings reported holding TMCI - TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value as of Q4 2023.
TREACE MEDICAL CONCEPTS, INC. - Common stock, $0.001 par value (TMCI) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.5K shares
of 63.2M outstanding shares and own 0.05% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (4.29M shares), BlackRock Inc. (3.69M shares), MORGAN STANLEY (3.12M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.87M shares), ARMISTICE CAPITAL, LLC (2.86M shares), Divisadero Street Capital Management, LP (1.75M shares), TimesSquare Capital Management, LLC (1.75M shares), CIBC Private Wealth Group, LLC (1.46M shares), EMERALD ADVISERS, LLC (1.45M shares), and STATE STREET CORP (1.42M shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.